Novavax (NVAX) Misses Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts NVAX Hot Sheet
Price: $3.93 +1.03%
EPS Growth %: +72.1%
Financial Fact:
Net loss: -66.25M
Today's EPS Names:
MAXN, CSTR, ACU, More
EPS Growth %: +72.1%
Financial Fact:
Net loss: -66.25M
Today's EPS Names:
MAXN, CSTR, ACU, More
Join SI Premium – FREE
Novavax (NASDAQ: NVAX) reported Q3 EPS of ($0.08), $0.01 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $8.2 million versus the consensus estimate of $9.2 million.
For earnings history and earnings-related data on Novavax (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Super Micro Computer (SMCI) Falls 6%
- P&G lifts annual profit forecast on strong US consumer demand, easing costs
- Wipro (WIT) Tops Q1 EPS by 1c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
